Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 107–107 | Cite as

Denosumab

Hypocalcaemia: case report
Case report
  • 13 Downloads

Reference

  1. Ishikawa K, et al. High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis. Clinical Interventions in Aging 13: 1929-1934, 8 Oct 2018. Available from: URL: http://doi.org/10.2147/CIA.S180614 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations